ABSTRACT
Objective To explore the clinical effect of single use or combination of dydrogesterone and progestin in treatment of threatened abortion caused by uteal phase defect.Methods Totally 186 patients with threatened abortion caused by uteal phase defect accepted in The First Affiliated Hospital of Henan from April 2015 to April 2016 were selected and randomly divided into groups A,B,and C with 62 cases in each group.Patients in group A were given dydrogesterone,those in group B were given progestin,and those in group C were given dydrogesterone combined with progestin.Then the clinical effect,expression of hormones,treatment outcome,and adverse reaction were observed and compared.Results The total effective rates of groups A and B were 72.58％ and 66.13％,respectively,which were obviously lower than 90.32％ of group C with statistically significance (P ＜0.05).The expression levels of P,E2,and hCG of three groups after treatment were higher than those before,those in group C were the highest among them (P ＜ 0.05).The successful treatment rates of groups A,B,and C were 83.87％,82.26％,and 95.16％,respectively,which had no great difference.Conclusion Combination use of dydrogesterone and progestin has better effective rate in treatment of threatened abortion caused by uteal phase defect compared to single use of these two drugs,which has good safety and worth of clinical application.
ABSTRACT
ObjectiveTo investigate the relationship between hepatitis B markers and HBV-DNA content.Methods230 cases with hepatitis were selected.ELISA method was used to detect serum markers,PCR method fordetecting the content of HBV-DNA.ResultsIn 76cases of HBeAg positive specimens,72 cases were HBV-DNA positive,the positive rate was 94.7％ ; in 154 patients with HBeAg negative specimens,72 cases were HBV-DNA posifive,the positive rate was 46.7％.The difference between HBeAg positive group and HBeAg negative group was statistically different( P ＜0.01 ).ConclusionIn patients with chronic hepatitis B,serum markers reflected,HBV can understand the in vivo infection,cannot directly reflect the in vivo replication of HBV.Detection of HBV-DNA content can better reflect the virus replication.
ABSTRACT
Objective To study the bioactive constituents of the immature fruits of Citrus aurantium. Methods Silica gel and Sephadex LH-20 were used to isolate the constituents of this plant. The spectroscopic methods were applied for their structural elucidation. Results Four compounds were isolated from the ethanol extract of the immature fruits of C. aurantium. These compounds were elucidated as 3, 5-dihydroxyphenyl 1-O-(6′-O-trans-feruloyl)-?-D-glucopyranoside (Ⅰ), hesperetin (Ⅱ), 4′, 5, 7, 8-tetra- methoxyflavone (Ⅲ), and limonin (Ⅳ). Conclusion Compound Ⅰ is a new phenolic glycoside.